[Usefulness of N-terminal type B natriuretic propeptide in amyloidosis]
Secco A, Ciapponi A, Pichon-Riviere A, Augustovski F, García Martí S, Alcaraz A, Bardach A, López A, Rey-Ares L
Record ID 32017000275
Spanish
Authors' recommendations:
Evidence of moderate methodological quality shows the usefulness of N-terminal type B natriuretic propeptide in assessing the prognosis in light-chain and transthyretin deposit amyloidosis. Low quality evidence demonstrates its usefulness in assessing treatment response in light-chain amyloidosis.
The clinical practice guidelines do recommend it for both indications in light-chain amyloidosis.
No health technology assessments were found and the United States health sponsors evaluated do not mention its coverage for that indication.
Details
Project Status:
Completed
Year Published:
2017
URL for published report:
www.iecs.org.ar/home-ets/
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Argentina
MeSH Terms
- Amyloidosis
- Atrial Natriuretic Factor
- Diuretics
- Humans
Contact
Organisation Name:
Institute for Clinical Effectiveness and Health Policy
Contact Address:
Dr. Emilio Ravignani 2024, Buenos Aires - Argentina, C1414 CABA
Contact Name:
info@iecs.org.ar
Contact Email:
info@iecs.org.ar
Copyright:
Institute for Clinical Effectiveness and Health Policy (IECS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.